Oxcarbazepine
Product Images NDC 68071-2973

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 68071-2973). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2978 3)

Label for Miconazole Nitrate 2% cream, 1.05 oz, packaged by NuCare Pharmaceuticals, Inc. in Orange, CA, and manufactured by EzriCare LLC in Lakewood, NJ. The label includes usage instructions, lot number, expiration date, serial number, and storage conditions of 68-77°F. It advises to keep out of reach of children and consult a doctor for side effects.*

FDA Label Image

Figure1 (Figure1)

A Kaplan-Meier survival curve comparing oxcarbazepine and placebo groups over 9 days from Day 2 8 am to Day 11 8 am. The graph shows the event rate on the Y-axis and time on trial in days on the X-axis, with oxcarbazepine represented by a solid line and placebo by a dashed line. A log-rank test p-value of 0.0001 is noted.*

FDA Label Image

Figure2 (Figure2)

A Kaplan-Meier curve showing seizure rate over days from first dose to first seizure comparing Oxcarbazepine and placebo groups. The graph includes a log-rank test with a p-value of 0.046, indicating a statistical comparison between the two groups' seizure rates over time.*

FDA Label Image

Figure3 (Figure3)

A Kaplan-Meier survival curve graph showing cumulative exit rates over time (days) for two groups labeled as High and Low. The plot includes a log-rank test p-value of 0.0001, indicating statistical comparison between groups. The x-axis represents time to exit in days, and the y-axis shows the exit rate ranging from 0 to 1.0.*

FDA Label Image

Figure4 (Figure4)

A Kaplan-Meier survival curve showing the exit rate over time in days for two treatment groups labeled HIGH and LOW. The LOW group has a higher exit rate with a steep increase before 50 days, compared to the slower, gradual increase for the HIGH group. A log-rank test with p-value 0.0001 is noted on the chart.*

FDA Label Image

Logo (Logo)

FDA Label Image

Structure (Structure)

Chemical structure of Oxcarbazepine, showing its molecular framework including a ketone group, amide group, and aromatic rings, as submitted by NuCare Pharmaceuticals, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.